132 related articles for article (PubMed ID: 10733939)
1. CD39 modulates IL-1 release from activated endothelial cells.
Imai M; Goepfert C; Kaczmarek E; Robson SC
Biochem Biophys Res Commun; 2000 Apr; 270(1):272-8. PubMed ID: 10733939
[TBL] [Abstract][Full Text] [Related]
2. Beneficial effects of CD39/ecto-nucleoside triphosphate diphosphohydrolase-1 in murine intestinal ischemia-reperfusion injury.
Guckelberger O; Sun XF; Sévigny J; Imai M; Kaczmarek E; Enjyoji K; Kruskal JB; Robson SC
Thromb Haemost; 2004 Mar; 91(3):576-86. PubMed ID: 14983235
[TBL] [Abstract][Full Text] [Related]
3. Ectonucleoside triphosphate diphosphohydrolase 1/CD39, localized in neurons of human and porcine heart, modulates ATP-induced norepinephrine exocytosis.
Machida T; Heerdt PM; Reid AC; Schäfer U; Silver RB; Broekman MJ; Marcus AJ; Levi R
J Pharmacol Exp Ther; 2005 May; 313(2):570-7. PubMed ID: 15647328
[TBL] [Abstract][Full Text] [Related]
4. CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness.
Mizumoto N; Kumamoto T; Robson SC; Sévigny J; Matsue H; Enjyoji K; Takashima A
Nat Med; 2002 Apr; 8(4):358-65. PubMed ID: 11927941
[TBL] [Abstract][Full Text] [Related]
5. Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation.
Robson SC; Wu Y; Sun X; Knosalla C; Dwyer K; Enjyoji K
Semin Thromb Hemost; 2005 Apr; 31(2):217-33. PubMed ID: 15852225
[TBL] [Abstract][Full Text] [Related]
6. CD39 modulates endothelial cell activation and apoptosis.
Goepfert C; Imai M; Brouard S; Csizmadia E; Kaczmarek E; Robson SC
Mol Med; 2000 Jul; 6(7):591-603. PubMed ID: 10997340
[TBL] [Abstract][Full Text] [Related]
7. Soluble apyrases release adp during ATP hydrolysis.
Chen W; Guidotti G
Biochem Biophys Res Commun; 2001 Mar; 282(1):90-5. PubMed ID: 11263976
[TBL] [Abstract][Full Text] [Related]
8. Role of CD39 (NTPDase-1) in thromboregulation, cerebroprotection, and cardioprotection.
Marcus AJ; Broekman MJ; Drosopoulos JH; Olson KE; Islam N; Pinsky DJ; Levi R
Semin Thromb Hemost; 2005 Apr; 31(2):234-46. PubMed ID: 15852226
[TBL] [Abstract][Full Text] [Related]
9. Metabolic control of excessive extracellular nucleotide accumulation by CD39/ecto-nucleotidase-1: implications for ischemic vascular diseases.
Marcus AJ; Broekman MJ; Drosopoulos JH; Islam N; Pinsky DJ; Sesti C; Levi R
J Pharmacol Exp Ther; 2003 Apr; 305(1):9-16. PubMed ID: 12649347
[TBL] [Abstract][Full Text] [Related]
10. Involvement of multiple P2Y receptors and signaling pathways in the action of adenine nucleotides diphosphates on human monocyte-derived dendritic cells.
Marteau F; Communi D; Boeynaems JM; Suarez Gonzalez N
J Leukoc Biol; 2004 Oct; 76(4):796-803. PubMed ID: 15240747
[TBL] [Abstract][Full Text] [Related]
11. Extracellular ATP inhibits IL-1-induced MMP-1 expression through the action of CD39/nucleotidase triphosphate dephosphorylase-1 on human gingival fibroblasts.
Nemoto E; Gotoh K; Tsuchiya M; Sakisaka Y; Shimauchi H
Int Immunopharmacol; 2013 Nov; 17(3):513-8. PubMed ID: 23941770
[TBL] [Abstract][Full Text] [Related]
12. Analysis of CD39/ATP diphosphohydrolase (ATPDase) expression in endothelial cells, platelets and leukocytes.
Koziak K; Sévigny J; Robson SC; Siegel JB; Kaczmarek E
Thromb Haemost; 1999 Nov; 82(5):1538-44. PubMed ID: 10595651
[TBL] [Abstract][Full Text] [Related]
13. Modulation of nucleoside [correction of nucleotide] triphosphate diphosphohydrolase-1 (NTPDase-1)cd39 in xenograft rejection.
Imai M; Takigami K; Guckelberger O; Enjyoji K; Smith RN; Lin Y; Csizmadia E; Sévigny J; Rosenberg RD; Bach FH; Robson SC
Mol Med; 1999 Nov; 5(11):743-52. PubMed ID: 10656876
[TBL] [Abstract][Full Text] [Related]
14. Adenosine and inflammation: CD39 and CD73 are critical mediators in LPS-induced PMN trafficking into the lungs.
Reutershan J; Vollmer I; Stark S; Wagner R; Ngamsri KC; Eltzschig HK
FASEB J; 2009 Feb; 23(2):473-82. PubMed ID: 18838482
[TBL] [Abstract][Full Text] [Related]
15. Structural elements and limited proteolysis of CD39 influence ATP diphosphohydrolase activity.
Schulte am Esch J; Sévigny J; Kaczmarek E; Siegel JB; Imai M; Koziak K; Beaudoin AR; Robson SC
Biochemistry; 1999 Feb; 38(8):2248-58. PubMed ID: 10029517
[TBL] [Abstract][Full Text] [Related]
16. CD39 as a caveolar-associated ectonucleotidase.
Kittel A; Kaczmarek E; Sevigny J; Lengyel K; Csizmadia E; Robson SC
Biochem Biophys Res Commun; 1999 Sep; 262(3):596-9. PubMed ID: 10471369
[TBL] [Abstract][Full Text] [Related]
17. Assignment of ecto-nucleoside triphosphate diphosphohydrolase-1/cd39 expression to microglia and vasculature of the brain.
Braun N; Sévigny J; Robson SC; Enjyoji K; Guckelberger O; Hammer K; Di Virgilio F; Zimmermann H
Eur J Neurosci; 2000 Dec; 12(12):4357-66. PubMed ID: 11122346
[TBL] [Abstract][Full Text] [Related]
18. Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation.
Enjyoji K; Sévigny J; Lin Y; Frenette PS; Christie PD; Esch JS; Imai M; Edelberg JM; Rayburn H; Lech M; Beeler DL; Csizmadia E; Wagner DD; Robson SC; Rosenberg RD
Nat Med; 1999 Sep; 5(9):1010-7. PubMed ID: 10470077
[TBL] [Abstract][Full Text] [Related]
19. Expression and characterization of human ecto-ATPase and chimeras with CD39 ecto-apyrase.
Hicks-Berger CA; Kirley TL
IUBMB Life; 2000 Jul; 50(1):43-50. PubMed ID: 11087120
[TBL] [Abstract][Full Text] [Related]
20. Characterization of NTPDase (NTPDase1; ecto-apyrase; ecto-diphosphohydrolase; CD39; EC 3.6.1.5) activity in human lymphocytes.
Leal DB; Streher CA; Neu TN; Bittencourt FP; Leal CA; da Silva JE; Morsch VM; Schetinger MR
Biochim Biophys Acta; 2005 Jan; 1721(1-3):9-15. PubMed ID: 15652174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
